Press Release

Global Human Coagulation Factor VIII market is valued at 7440 million US$ in 2018 is expected to reach 9420 million US$ by the end of 2025, growing at a CAGR of 3.0% during 2019-2025

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market […]

Read More